ITCI
Intra-Cellular Therapies, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +7.1% ·
share flow +6.3% ·
net new positions +6.7%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank ✦ (passive) | 3.21M | +0.5% | $268.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 1.87M | — | $156.59M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.72M | +0.5% | $143.43M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Marshall Wace ✦ | 1.08M | -7.0% | $90.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.03M | +1.6% | $86.34M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 6 | Adage Capital Partners ✦ | 678.00K | +266.5% | $56.63M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 589.91K | -43.4% | $49.27M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 536.78K | +16.2% | $44.83M | 0.1% | ▲ Add | 3 | SEC ↗ ×3 |
| 9 | D. E. Shaw & Co. ✦ | 534.46K | +45.0% | $44.64M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 520.83K | +4.3% | $43.50M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 314.50K | +60.3% | $26.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 251.82K | +110.1% | $21.03M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 142.79K | +507.9% | $11.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 118.02K | New | $9.86M | 0.0% | New | 1 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 11.01K | +15.8% | $919,305 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $9.86M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 1 shares, $2,540 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.